ESTRO 2024 - Abstract Book

S1315

Clinical - Head & neck

ESTRO 2024

[2] Schindler A, Denaro N, Russi EG, Pizzorni N, Bossi P, Merlotti A, et al. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. Critical Reviews in Oncology/Hematology 2015;96:372 – 84. https://doi.org/10.1016/j.critrevonc.2015.06.005. [3] Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, et al. Weekly Low ‐ Dose Versus Three ‐ Weekly High ‐ Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non ‐ Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta ‐ Analysis of Aggregate Data. The Oncol 2017;22:1056 – 66. https://doi.org/10.1634/theoncologist.2017-0015. [4] Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis. JCO 2008;26:3582 – 9. https://doi.org/10.1200/JCO.2007.14.8841. [5] Russi EG, Corvò R, Merlotti A, Alterio D, Franco P, Pergolizzi S, et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: Review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treatment Reviews 2012;38:1033 – 49. https://doi.org/10.1016/j.ctrv.2012.04.002. [6] Mirabile A, Numico G, Russi EG, Bossi P, Crippa F, Bacigalupo A, et al. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. Critical Reviews in Oncology/Hematology 2015;95:191 – 213. https://doi.org/10.1016/j.critrevonc.2015.03.003. [7] Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MWS, et al. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer 2012;118:5793 – 9. https://doi.org/10.1002/cncr.27631. [8] Jensen K, Lambertsen K, Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007;85:74 – 82. https://doi.org/10.1016/j.radonc.2007.06.004. [9] Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch C-A, et al. Toxicities Affecting Quality of Life After Chemo-IMRT of Oropharyngeal Cancer: Prospective Study of Patient-Reported, Observer-Rated, and Objective Outcomes. International Journal of Radiation Oncology*Biology*Physics 2013;85:935 – 40. https://doi.org/10.1016/j.ijrobp.2012.08.030. [10] Cusumano D, Boldrini L, Dhont J, Fiorino C, Green O, Güngör G, et al. Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives. Physica Medica 2021;85:175 – 91. https://doi.org/10.1016/j.ejmp.2021.05.010. [11] Cilla S, Deodato F, Romano C, Ianiro A, Macchia G, Re A, et al. Personalized automation of treatment planning in head-neck cancer: A step forward for quality in radiation therapy? Physica Medica 2021;82:7 – 16. https://doi.org/10.1016/j.ejmp.2020.12.015. [12] Placidi L, Nardini M, Cusumano D, Boldrini L, Chiloiro G, Romano A, et al. VMAT-like plans for magnetic resonance guided radiotherapy: Addressing unmet needs. Physica Medica 2021;85:72 – 8. https://doi.org/10.1016/j.ejmp.2021.05.002.

[13] Cusumano D, Boldrini L, Yadav P, Yu G, Musurunu B, Chiloiro G, et al. External Validation of Early Regression Index (ERITCP) as Predictor of Pathologic Complete Response in Rectal Cancer Using Magnetic Resonance-Guided